Continuous Advate IV Effectively Prevented Bleeds in Surgery

Continuous Advate IV Effectively Prevented Bleeds in Surgery

291311

Continuous Advate IV Effectively Prevented Bleeds in Surgery

Continuous into-the-vein (intravenous) infusions of Advate immediately before and after major orthopedic surgery is as safe and effective as standard, short, bolus infusions at preventing bleeds in men with moderate-to-severe hemophilia A. That finding from a Phase 3/4 clinical trial — the first controlled trial to compare the two types of treatment administration — suggests continuous infusion may be a viable alternative to bolus infusion in hemophilia A patients undergoing major surgery requiring drain placement. Trial data…

You must be logged in to read/download the full post.